Hunter Syndrome Treatment Market Size, Share & Trends Analysis Report By Type (Enzyme Replacement Therapy, Hematopoietic Stem Cell Transplant), By Route Of Administration, By End Use, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED: October 15, 2024

PAGES: 100 Pages

DELIVERY TIME: 2-10 business days

SELECT AN OPTION

The global hunter syndrome treatment market size is expected to reach a value of USD 1.78 billion by 2030, expanding at a CAGR of 5.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. High unmet needs, robust pipeline, increasing awareness about this rare disease and growing R&D activities for the development of novel therapies are expected to drive market growth over the forecast period.

Hunter syndrome, also referred as mucopolysaccharidosis type II (MPS II), is a rare genetic disorder caused by the missing or malfunctioning iduronate-2-sulfatase enzyme. According to the data published by the National Institute of Neurological Disorders and Stroke, MPS II syndrome occurs in around 1 in every 100,000 to 150,000 male births.

Presently, there are no approved curative therapies for the treatment of Hunter syndrome. The available treatment options such as enzyme replacement therapy (ERT) and hematopoietic stem cell transplant (HSCT) are focused on providing symptomatic relief and management of complications associated with disease progression. Shire plc's Elaprase (idursulfase) is the only key drug available for the treatment of Hunter syndrome worldwide, with GC Pharma's Hunterase (idursulfase beta) being approved only in South Korea.

Key players are focused on extensive R&D activities for product development and gaining approval as novel therapies. Launch of such novel therapies in the near future is expected to significantly fuel the Hunter syndrome treatment market growth. For instance, in May 2018, REGENXBIO Inc. received the U.S. FDA's Fast Track designation for its novel drug candidate RGX-121, indicated for the disease treatment.

Hunter Syndrome Treatment Market Report Highlights:

The intravenous segment led the market and accounted for the largest revenue share of 72.3% in 2024 attributed to its established effectiveness in delivering enzyme replacement therapies (ERT).
Enzyme replacement therapy (ERT) led the market and accounted for the largest revenue share of 57.3% in 2024 driven by its ability to address the deficiency of the enzyme iduronate-2-sulfatase.
Hospitals held the dominant position in the market, accounting for the largest revenue share of 63.1% in 2024 attributed to their capacity to provide comprehensive care and advanced medical resources.
North America hunter syndrome treatment market dominated the global market and accounted for the largest revenue share of 37.5% in 2024 attributed to a combination of advanced healthcare infrastructure and increasing awareness of rare diseases.

Product Code: GVR-2-68038-743-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Technology
- 1.2.3. Test
- 1.2.4. Type
- 1.2.5. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Hunter Syndrome Treatment Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Hunter Syndrome Treatment Market: Type Business Analysis

4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Enzyme Replacement Therapy (ERT)
- 4.4.1. Enzyme Replacement Therapy (ERT) Market, 2018 - 2030 (USD Million)
4.5. Hematopoietic Stem Cell Transplant (HSCT)
- 4.5.1. Hematopoietic Stem Cell Transplant (HSCT) Market, 2018 - 2030 (USD Million)
4.6. Others
- 4.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Hunter Syndrome Treatment Market: Route of Administration Business Analysis

5.1. Route of Administration Market Share, 2024 & 2030
5.2. Route of Administration Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
5.4. Intravenous
- 5.4.1. Intravenous Market, 2018 - 2030 (USD Million)
5.5. Intracerebroventricular (ICV)/ Intrathecal
- 5.5.1. Intracerebroventricular (ICV)/Intrathecal Market, 2018 - 2030 (USD Million)

Chapter 6. Hunter Syndrome Treatment Market: End Use Business Analysis

6.1. End Use Market Share, 2024 & 2030
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
- 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
6.5. Specialty Clinics
- 6.5.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
6.6. Others
- 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Hunter Syndrome Treatment Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
- 7.4.1. North America Hunter Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework
  - 7.4.2.3. Competitive insights
  - 7.4.2.4. U.S. hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework
  - 7.4.3.3. Competitive insights
  - 7.4.3.4. Canada hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Regulatory framework
  - 7.4.4.3. Competitive insights
  - 7.4.4.4. Mexico hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Europe
- 7.5.1. Europe Hunter Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework
  - 7.5.2.3. Competitive insights
  - 7.5.2.4. UK hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework
  - 7.5.3.3. Competitive insights
  - 7.5.3.4. Germany hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework
  - 7.5.4.3. Competitive insights
  - 7.5.4.4. France hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework
  - 7.5.5.3. Competitive insights
  - 7.5.5.4. Italy hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework
  - 7.5.6.3. Competitive insights
  - 7.5.6.4. Spain hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Norway
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Regulatory framework
  - 7.5.7.3. Competitive insights
  - 7.5.7.4. Norway hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Denmark
  - 7.5.8.1. Key country dynamics
  - 7.5.8.2. Regulatory framework
  - 7.5.8.3. Competitive insights
  - 7.5.8.4. Denmark hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Sweden
  - 7.5.9.1. Key country dynamics
  - 7.5.9.2. Regulatory framework
  - 7.5.9.3. Competitive insights
  - 7.5.9.4. Sweden hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Hunter Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework
  - 7.6.2.3. Competitive insights
  - 7.6.2.4. Japan hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework
  - 7.6.3.3. Competitive insights
  - 7.6.3.4. China hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Regulatory framework
  - 7.6.4.3. Competitive insights
  - 7.6.4.4. India hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Regulatory framework
  - 7.6.5.3. Competitive insights
  - 7.6.5.4. South Korea hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Australia
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Regulatory framework
  - 7.6.6.3. Competitive insights
  - 7.6.6.4. Australia hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Key country dynamics
  - 7.6.7.2. Regulatory framework
  - 7.6.7.3. Competitive insights
  - 7.6.7.4. Thailand hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Hunter Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework
  - 7.7.2.3. Competitive insights
  - 7.7.2.4. Brazil hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework
  - 7.7.3.3. Competitive insights
  - 7.7.3.4. Argentina hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. MEA
- 7.8.1. MEA Hunter Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Regulatory framework
  - 7.8.2.3. Competitive insights
  - 7.8.2.4. South Africa hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Regulatory framework
  - 7.8.3.3. Competitive insights
  - 7.8.3.4. Saudi Arabia hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key country dynamics
  - 7.8.4.2. Regulatory framework
  - 7.8.4.3. Competitive insights
  - 7.8.4.4. UAE hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key country dynamics
  - 7.8.5.2. Regulatory framework
  - 7.8.5.3. Competitive insights
  - 7.8.5.4. Kuwait hunter syndrome treatment market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. Takeda Pharmaceutical Company Limited
  - 8.5.1.1. Overview
  - 8.5.1.2. Financial performance
  - 8.5.1.3. Type benchmarking
  - 8.5.1.4. Strategic initiatives
- 8.5.2. F. Hoffmann-La Roche Ltd.
  - 8.5.2.1. Overview
  - 8.5.2.2. Financial performance
  - 8.5.2.3. Type benchmarking
  - 8.5.2.4. Strategic initiatives
- 8.5.3. Abbott
  - 8.5.3.1. Overview
  - 8.5.3.2. Financial performance
  - 8.5.3.3. Type benchmarking
  - 8.5.3.4. Strategic initiatives
- 8.5.4. Denali Therapeutics
  - 8.5.4.1. Overview
  - 8.5.4.2. Financial performance
  - 8.5.4.3. Type benchmarking
  - 8.5.4.4. Strategic initiatives
- 8.5.5. Medtronic
  - 8.5.5.1. Overview
  - 8.5.5.2. Financial performance
  - 8.5.5.3. Type benchmarking
  - 8.5.5.4. Strategic initiatives
- 8.5.6. Johnson & Johnson Services, Inc.
  - 8.5.6.1. Overview
  - 8.5.6.2. Financial performance
  - 8.5.6.3. Type benchmarking
  - 8.5.6.4. Strategic initiatives
- 8.5.7. GSK Plc.
  - 8.5.7.1. Overview
  - 8.5.7.2. Financial performance
  - 8.5.7.3. Type benchmarking
  - 8.5.7.4. Strategic initiatives
- 8.5.8. Bayer AG
  - 8.5.8.1. Overview
  - 8.5.8.2. Financial performance
  - 8.5.8.3. Type benchmarking
  - 8.5.8.4. Strategic initiatives
- 8.5.9. Zimmer Biomet
  - 8.5.9.1. Overview
  - 8.5.9.2. Financial performance
  - 8.5.9.3. Type benchmarking
  - 8.5.9.4. Strategic initiatives
- 8.5.10. Stryker Corporation
  - 8.5.10.1. Overview
  - 8.5.10.2. Financial performance
  - 8.5.10.3. Type benchmarking
  - 8.5.10.4. Strategic initiatives
- 8.5.11. Homology Medicines, Inc.
  - 8.5.11.1. Overview
  - 8.5.11.2. Financial performance
  - 8.5.11.3. Type benchmarking
  - 8.5.11.4. Strategic initiatives
- 8.5.12. Novartis AG
  - 8.5.12.1. Overview
  - 8.5.12.2. Financial performance
  - 8.5.12.3. Type benchmarking
  - 8.5.12.4. Strategic initiatives

Product Code: GVR-2-68038-743-8

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Hunter Syndrome Treatment Market, by Region, 2018 - 2030 (USD Million)
Table 4 Global Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 5 Global Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 6 Global Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 7 North America Hunter Syndrome Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 9 North America Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 10 North America Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 11 U.S. Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 12 U.S. Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 13 U.S. Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 14 Canada Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 15 Canada Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 16 Canada Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 17 Mexico Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 18 Mexico Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 19 Mexico Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 20 Europe Hunter Syndrome Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 21 Europe Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 22 Europe Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 23 Europe Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 24 UK Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 25 UK Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 26 UK Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 27 Germany Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 28 Germany Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 29 Germany Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 30 France Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 31 France Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 32 France Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 33 Italy Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 34 Italy Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 35 Italy Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 36 Spain Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 37 Spain Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 38 Spain Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 39 Norway Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 40 Norway Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 41 Norway Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 42 Denmark Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 43 Denmark Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 44 Denmark Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 45 Sweden Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 46 Sweden Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 47 Sweden Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Hunter Syndrome Treatment Market, by country, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 52 Japan Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 53 Japan Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 54 Japan Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 55 China Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 56 China Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 57 China Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 58 India Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 59 India Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 60 India Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 61 Australia Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 62 Australia Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 63 Australia Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 64 South Korea Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 65 South Korea Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 66 South Korea Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 67 Thailand Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 68 Thailand Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 69 Thailand Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 70 Latin America Hunter Syndrome Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 71 Latin America Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 72 Latin America Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 73 Latin America Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 74 Brazil Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 75 Brazil Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 76 Brazil Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 77 Argentina Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 78 Argentina Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 79 Argentina Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Hunter Syndrome Treatment Market, by country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 84 South Africa Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 85 South Africa Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 86 South Africa Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 90 UAE Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 91 UAE Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 92 UAE Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)
Table 93 Kuwait Hunter Syndrome Treatment Market, by Type, 2018 - 2030 (USD Million)
Table 94 Kuwait Hunter Syndrome Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
Table 95 Kuwait Hunter Syndrome Treatment Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Hunter Syndrome Treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Segment outlook (USD Million)
Fig. 10 Segment outlook (USD Million)
Fig. 11 Competitive landscape
Fig. 12 Hunter syndrome treatment market dynamics
Fig. 13 Hunter syndrome treatment market: Porter's five forces analysis
Fig. 14 Hunter syndrome treatment market: PESTLE analysis
Fig. 15 Hunter syndrome treatment market: Type segment dashboard
Fig. 16 Hunter syndrome treatment market: Type market share analysis, 2024 & 2030
Fig. 17 Enzyme replacement therapy (ERT) market, 2018 - 2030 (USD Million)
Fig. 18 Hematopoietic stem cell transplant (HSCT) market, 2018 - 2030 (USD Million)
Fig. 19 Others market, 2018 - 2030 (USD Million)
Fig. 20 Hunter syndrome treatment market: Route of Administration segment dashboard
Fig. 21 Hunter syndrome treatment market: Route of Administration market share analysis, 2024 & 2030
Fig. 22 Intravenous market, 2018 - 2030 (USD Million)
Fig. 23 Intracerebroventricular (ICV)/Intrathecal market, 2018 - 2030 (USD Million)
Fig. 24 Hunter syndrome treatment market: End use segment dashboard
Fig. 25 Hunter syndrome treatment market: End use market share analysis, 2024 & 2030
Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
Fig. 27 Specialty clinics laboratories market, 2018 - 2030 (USD Million)
Fig. 28 Others market, 2018 - 2030 (USD Million)
Fig. 29 Hunter syndrome treatment market revenue, by region
Fig. 30 Regional marketplace: Key takeaways
Fig. 31 Regional marketplace: Key takeaways
Fig. 32 North America hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 33 U.S. country dynamics
Fig. 34 U.S. hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 35 Canada country dynamics
Fig. 36 Canada hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 37 Mexico country dynamics
Fig. 38 Mexico hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 39 Europe hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 40 UK country dynamics
Fig. 41 UK hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 42 Germany country dynamics
Fig. 43 Germany hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 44 France country dynamics
Fig. 45 France hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 46 Italy country dynamics
Fig. 47 Italy hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 48 Spain country dynamics
Fig. 49 Spain hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 50 Norway country dynamics
Fig. 51 Norway hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 52 Sweden country dynamics
Fig. 53 Sweden hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 54 Denmark country dynamics
Fig. 55 Denmark hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 56 Asia Pacific hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 57 Japan country dynamics
Fig. 58 Japan hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 59 China country dynamics
Fig. 60 China hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 61 India country dynamics
Fig. 62 India hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 63 Australia country dynamics
Fig. 64 Australia hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 65 South Korea country dynamics
Fig. 66 South Korea hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 67 Thailand country dynamics
Fig. 68 Thailand hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 69 Latin America hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 70 Brazil country dynamics
Fig. 71 Brazil hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 72 Argentina country dynamics
Fig. 73 Argentina hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 74 MEA hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 75 South Africa country dynamics
Fig. 76 South Africa hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 77 Saudi Arabia country dynamics
Fig. 78 Saudi Arabia hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 79 UAE country dynamics
Fig. 80 UAE hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 81 Kuwait Key country dynamicss
Fig. 82 Kuwait hunter syndrome treatment market, 2018 - 2030 (USD Million)
Fig. 83 Company categorization
Fig. 84 Company market position analysis
Fig. 85 Strategic framework